Somnomed Limited · ASX:SOM
Somnomed — Investor Presentation (June 2008)
13 slides from Somnomed's investor presentation, June 2008
Slide 1: SomnoMed
SomnolVled ‘This presentation conaitsomardovking statements that mohe jes and unceranies, These fonaddouking statment are cot ‘ateialy fom the esuls dscussed i hese statemenis Facto: thalmaht cause the Companys result to dffer matty fem those ‘ooressed 01 inpled by uch fomatdlookng statements nolude
Slide 2: SomnoMed company overview
• SomnoMed is a Sydney-based ASX (SOM) - listed company which was formed in 2004 to commercialise its patented mandibular advancement splint, the SomnoDent™ MAS. • The SomnoDent™ MAS is a clinically-tested medical device which has proved to be highly effective in treating mild to moderate obstructiv
Slide 3: Obstructive Sleep Apnea (OSA) - a night time breathing disorder
Obstructive Sleep Apnea (OSA) ~ a night time breathing disorder • The upper airway narrows, or collapses during sleep • Periods of apnea may interrupt breathing hundreds of times a night Key signs and symptoms • Excessive daytime sleepiness • Grogginess and morning headaches • Loud or disruptive sno
Slide 4: Obstructive Sleep Apnea (OSA) - a global healthcare challenge
Obstructive Sleep Apnea (OSA) ~ a global healthcare challenge • 1 billion people snore (40-60% of all people over the age of 50) • 100-200 million people suffer from obstructive sleep apnea (OSA), causing long- term health risks • Increased risk of heart disease, high blood pressure, stroke, and imp
Slide 5: OSA treatment options
OSA treatment options Surgery Irreversible Success rate *50% Painful, slow recovery Very expensive CPAP Success rate *100% (Continuous Positive Airway Compliance <50% Pressure) Expensive MAS device Success rate *50-70% (Mandibular Advancement Splint) Comfortable Compliance >90% Least expensive *Succ
Slide 6: How does the device work?
How does the device work? • SomnoDent™ MAS prevents the collapse of the lower airways, which causes snoring and sleep apnea • Device holds the lower jaw forward, which tightens these muscles to prevent collapse and keep the airways free from obstruction • 2 independent plates design allowing normal
Slide 7: SomnoDent MAS
SomnoDent™ MAS Mandibular Advancement Splint • Patented oral device • FDA, CE, TGA, ISO, Swiss Medic approved and certified • Custom-made • Clinically-tested • Highly effective in preventing mild to moderate OSA • Stops snoring in over 90% of the cases • 15,000 devices sold today; proven track recor
Slide 8: OSA Global Market Size Projection
OSA Global Market Size Projection • 15 – 20% growth rate p.a. 6,000,000 • > 60% of diagnosed patients untreated 5,000,000 • Dramatic shift expected to more comfortable MAS device 4,000,000 # units 3,000,000 MAS CPAP 2,000,000 1,000,000 0 2007 2010 2013 2014 2018 • CPAP market expected to grow from 1
Slide 9: Unit Growth Projection
3 year - Growth Projection 25,000 2 2 ,0 0 0 20,000 #units 15,000 14 ,0 0 0 10,000 7 ,0 0 0 5,000 3 ,5 0 0 2 ,5 0 0 1,5 0 0 0 FY 04/05 FY 05/06 FY 06/07 FY 07/08 FY 08/09 FY 09/10 Source: Company estimates
Slide 10: SomnoMed's Growth Story
SomnoMed’s Growth Story • 2004 - SomnoMed Limited listed on the Australian Stock Exchange (ASX:SOM) • 2005 - Start up and infrastructure development • 2006 - Expansion into US market • 2007 - Restructure and new Management Expansion into European and Asian market • 2008 - SomnoDent™ MAS is a leading
Slide 11: Capital structure, funds available and shareholding structure
Capital structure, funds available and shareholding structure Total shares on issue 768 million Market capitalization $ 23.0 million (based on share price of 3.0 cents 06.06.2008) Cash available $ 6.3 million (31.03.2008) Current cash burn $ 150,000/month (based on 9 months 01.10.2007 - 31.03.2008)
Slide 12: Excellence in Dental Sleep Medicine
Excellence in Dental Sleep Medicine
Slide 13: Contacts
Contacts Chairman Dr Peter Neustadt Chief Executive Officer Mr. Ralf Barschow Address Level 3, 20 Clarke St Crows Nest, NSW, 2065 Australia Telephone +61 (0)2 9467 0400 Website www.somnomed.com.au